|
Volumn 21, Issue 1, 2013, Pages 333-347
|
Focused library development of 2-phenylacrylamides as broad spectrum cytotoxic agents
|
Author keywords
Acrylamides; Cytotoxicity; Focused library; Synthesis
|
Indexed keywords
2 (1H INDOLE 3 CARBONYL) 3 (3,4 DICHLOROPHENYL)ACRYLONITRILE;
2 (1H INDOLE 3 CARBONYL) 3 (4 (TRIFLUOROMETHYL)PHENYL)ACRYLONITRILE;
2 (1H INDOLE 3 CARBONYL) 3 (4 METHOXYPHENYL)ACRYLONITRILE;
2 (1H INDOLE 3 CARBONYL) 3 (4 NITROPHENYL)ACRYLONITRILE;
2 (1H INDOLE 3 CARBONYL) 3 (NAPHTHALEN 2 YL)ACRYLONITRILE;
2 (1H INDOLE 3 CARBONYL) 3 (PERFLUOROPHENYL)ACRYLONITRILE;
2 (1H INDOLE 3 CARBONYL) 3 4 TOLYLACRYLONITRILE;
2 (1H PYRROLE 2 CARBONYL) 3 (4 (TRIFLUOROMETHYL)PHENYL)ACRYLONITRILE;
2 (1H PYRROLE 2 CARBONYL) 3 4 TOLYLACRYLONITRILE;
2 CYANO 3 (5 (HYDROXYMETHYL)FURAN 2 YL) N (4 METHOXYBENZYL)ACRYLAMIDE;
2 CYANO 3 (FURAN 2 YL) N (4 METHOXYBENZYL)ACRYLAMIDE;
2 CYANO N (3,4 DICHLOROBENZYL) 3 (1H PYRROL 2 YL)ACRYLAMIDE;
2 CYANO N (4 METHOXYBENZYL) 3 (1H PYRROL 2 YL)ACRYLAMIDE;
2 CYANO N (4 METHOXYBENZYL) 3 (5 METHYLFURAN 2 YL)ACRYLAMIDE;
2 CYNO N (3,4 DICHLOROBENZYL) 3 (FURAN 2 YL)ACRYLAMIDE;
2 PHENYLACRYLAMIDE DERIVATIVE;
3 (1H INDOL 3 YL) 2 (1H PYRROLE 2 CARBONYL)ACRYLONITRILE;
3 (3,4 DICHLOROPHENYL) 2 (1H PYRROLE 2 CARBONYL)ACRYLONITRILE;
3 (4 CHLOROPHENYL) 2 (1H INDOLE 3 CARBONYL)ACRYLONITRILE;
3 (4 CHLOROPHENYL) 2 (1H PYRROLE 2 CARBONYL)ACRYLONITRILE;
3 (4 HYDROXYPHENYL) 2 (1H INDOLE 3 CARBONYL)ACRYLONITRILE;
3 (4 HYDROXYPHENYL) 2 (1H PYRROLE 2 CARBONYL)ACRYLONITRILE;
3 (4 METHOXYPHENYL) 2 (1H PYRROLE 2 CARBONYL)ACRYLONITRILE;
3 (4 NITROPHENYL) 2 (1H PYRROLE 2 CARBONYL)ACRYLONITRILE;
3 (5 BROMOFURAN 2 YL) 2 CYANO N (4 METHOXYBENZYL)ACRYLAMIDE;
3 (5 CHLOROFURAN 2 YL) 2 CYANO N (4 METHOXYBENZYL)ACRYLAMIDE;
3 (NAPHTHALEN 2 YL) 2 (1H PYRROLE 2 CARBONYL)ACRYLONITRILE;
3 (PENTAFLUOROPHENYL) 2 (1H PYRROLE 2 CARBONYL)ACRYLONITRILE;
CYTOTOXIC AGENT;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
APOPTOSIS;
ARTICLE;
ASTROCYTOMA;
BREAST CARCINOMA;
CANCER CELL CULTURE;
CANCER INHIBITION;
CARBON NUCLEAR MAGNETIC RESONANCE;
COLON CARCINOMA;
CONTROLLED STUDY;
DRUG POTENCY;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
GLIOBLASTOMA;
HUMAN;
HUMAN CELL;
LUNG CARCINOMA;
MALIGNANT NEOPLASTIC DISEASE;
NEUROBLASTOMA;
OVARY CARCINOMA;
PANCREAS CARCINOMA;
PHARMACOPHORE;
PROSTATE CARCINOMA;
PROTON NUCLEAR MAGNETIC RESONANCE;
SKIN CARCINOMA;
STRUCTURE ACTIVITY RELATION;
ACRYLAMIDES;
ANTINEOPLASTIC AGENTS;
CELL LINE, TUMOR;
CELL PROLIFERATION;
CYTOTOXINS;
DRUG SCREENING ASSAYS, ANTITUMOR;
HUMANS;
NEOPLASMS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84870886448
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2012.10.003 Document Type: Article |
Times cited : (25)
|
References (33)
|